CLONAL CYTOGENETIC ABNORMALITIES IN HODGKINS-DISEASE

被引:30
作者
LADANYI, M
PARSA, NZ
OFFIT, K
WACHTEL, MS
FILIPPA, DA
JHANWAR, SC
机构
[1] MEM SLOAN KETTERING CANC CTR,CYTOGENET SERV,NEW YORK,NY 10021
[2] MEM SLOAN KETTERING CANC CTR,SURG PATHOL SERV,NEW YORK,NY 10021
[3] MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,LYMPHOMA SERV,NEW YORK,NY 10021
关键词
D O I
10.1002/gcc.2870030408
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytogenetic studies of Hodgkin's disease (HD), in contrast to those of non-Hodgkin's lymphoma (NHL), have been limited to small numbers of cases with infrequently recurring aberrations, underscoring the need for additional studies in establishing a coherent cytogenetic picture of HD. Over a 6 1/2-year period, we received 95 specimens of HD for cytogenetic analysis. Analyzable chromosome preparations were obtained in 70 cases, of which 57 (81%) showed only normal metaphases. In the remaining 13 cases (19%), karyotypic abnormalities were observed that were nonclonal in 3 and clonal in 10. The latter 10 cases included 6 of the nodular sclerosis subtype, 3 mixed cellularity, and 1 lymphocyte-depleted; 8 of the specimens were obtained pretreatment and 2 posttreatment. Two of the cases had a clonal numerical aberration, monosomy 17 in one and trisomy 13 in the other, as their sole abnormality. The remaining 8 cases showed complex karyotypes with multiple structural rearrangements; in 3 of these, the abnormal clone was near-tetraploid. Bands involved more than once included 1p36, 1q21, and 4q35, each in 2 cases. Arms involved more than once included 6q (6q13,6q23), 9p (9p13,9p21), and 5q (5q15,5q35). Three patients had loss of part or all of 6q (del(6)(q13),del(6)(q23),i(6p)). Bands 14q32 and 18q21 were not involved in any case, contrary to some previous reports. Our results confirm the frequent occurrence of 1p, 1q, and 6q abnormalities in HD. In addition, we have identified a 5q35 breakpoint, which has recently been shown to be highly specific for Ki-1-positive NHL in a case of typical nodular sclerosis HD. Its presence in HD may represent a cytogenetic link between the two entities, which are immunophenotypically related but clinically and histologically distinct.
引用
收藏
页码:294 / 299
页数:6
相关论文
共 34 条
[1]  
[Anonymous], 1985, INT SYSTEM HUMAN CYT
[2]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[3]   KARYOTYPIC ABNORMALITIES AND IMMUNOGLOBULIN GENE REARRANGEMENTS IN HODGKINS-DISEASE [J].
BANKS, RE ;
GLEDHILL, S ;
ROSS, FM ;
KRAJEWSKI, A ;
DEWAR, AE ;
WEIRTHOMPSON, EM .
CANCER GENETICS AND CYTOGENETICS, 1991, 51 (01) :103-111
[4]   A REVIEW AND INTERPRETATION OF CYTOGENETIC ABNORMALITIES IDENTIFIED IN HODGKINS-DISEASE [J].
CABANILLAS, F .
HEMATOLOGICAL ONCOLOGY, 1988, 6 (03) :271-274
[5]   THE EXPRESSION OF THE CD3 ANTIGEN IN HODGKINS-DISEASE [J].
CIBULL, ML ;
STEIN, H ;
GATTER, KC ;
MASON, DY .
HISTOPATHOLOGY, 1989, 15 (06) :597-605
[6]  
COLES FB, 1988, MODERN PATHOL, V1, P274
[7]  
DALLENBACH FE, 1989, LANCET, V2, P828
[8]   CYTOGENETIC STUDIES OF HODGKINS-DISEASE - ANALYSIS OF INVOLVED LYMPH-NODES FROM 12 PATIENTS [J].
DENNIS, TR ;
STOCK, AD ;
WINBERG, CD ;
SHEIBANI, K ;
RAPPAPORT, H .
CANCER GENETICS AND CYTOGENETICS, 1989, 37 (02) :201-208
[9]  
DOHNER H, 1990, BLOOD, V76, P1614
[10]  
DOUGLASS EC, 1985, J NATL CANCER I, V75, P51